Clinical Trial Update: A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities [Phase 2]

View source ↗

Summary

Phase 2 trial of LY3502970 in adults with obesity or overweight and weight-related comorbidities completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• LY3502970

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight and Obesity | Phase 2 | Status: COMPLETED | Results posted: 2023-09-13